pPRIME-CMV-GFP-FF3 Citations (3)
Originally described in: A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells.Stegmeier F, Hu G, Rickles RJ, Hannon GJ, Elledge SJ Proc Natl Acad Sci U S A. 2005 Sep 13. 102(37):13212-7. PubMed Journal
Articles Citing pPRIME-CMV-GFP-FF3
Articles |
---|
Variegation and silencing in a lentiviral-based murine transgenic model. Baup D, Fraga L, Pernot E, Van Acker A, Vanherck AS, Breckpot K, Thielemans K, Schurmans S, Moser M, Leo O. Transgenic Res. 2010 Jun;19(3):399-414. doi: 10.1007/s11248-009-9318-4. Epub 2009 Aug 23. PubMed |
Developmental regulation of the composite CAG promoter activity in the murine T lymphocyte cell lineage. Baup D, Moser M, Schurmans S, Leo O. Genesis. 2009 Dec;47(12):799-804. doi: 10.1002/dvg.20569. PubMed |
A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis. Yu H, Artomov M, Brahler S, Stander MC, Shamsan G, Sampson MG, White JM, Kretzler M, Miner JH, Jain S, Winkler CA, Mitra RD, Kopp JB, Daly MJ, Shaw AS. J Clin Invest. 2016 Mar 1;126(3):1067-78. doi: 10.1172/JCI82592. Epub 2016 Feb 22. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.